Lantidra, First FDA-Approved Cellular Therapy to Treat Type 1 Diabetes

被引：1
|
作者：
Rios, Peter
McGarrigle, James J.
Lamonica, Giovanna
Li, Yi
Cook, Jennifer
Joshi, Ira
Ghani, Sofia
Cook, David
Lopez, Daisy
Nasir, Hafsa
Wang, Yong
Oberholzer, Jose
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-35-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
35-OR
引用
收藏
页数：2
相关论文
共 50 条
  • [21] FDA approves first cell therapy for type 1 diabetes
    Asher Mullard
    Nature Reviews Drug Discovery, 2023, 22 : 611 - 611
  • [22] The First FDA-Approved Oral Drug for Multiple Sclerosis: Fingolimod
    Akman-Demir, Gulen
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2011, 48 : 64 - 66
  • [23] Scientific journey to the first FDA-approved drug for eosinophilic esophagitis
    Rothenberg, Marc E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 150 (06) : 1325 - 1332
  • [24] Prescribing of FDA-approved and compounded hormone therapy differs by specialty
    Constantine, Ginger D.
    Archer, David F.
    Graham, Shelli
    Bernick, Brian A.
    Mirkin, Sebastian
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2016, 23 (10): : 1075 - 1082
  • [25] Lifileucel: FDA-approved T-cell therapy for melanoma
    Kwong, Mei Li M.
    Yang, James C.
    ONCOLOGIST, 2024, 29 (08): : 648 - 650
  • [26] Virtual Screening for FDA-Approved Drugs That Selectively Inhibit Arginase Type 1 and 2
    Detroja, Trishna Saha
    Samson, Abraham O.
    MOLECULES, 2022, 27 (16):
  • [27] Doxil® - The first FDA-approved nano-drug: Lessons learned
    Barenholz, Yechezkel
    JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) : 117 - 134
  • [28] FDA Greenlights First Cell Therapy for Adults With Type 1 Diabetes
    Harris, Emily
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (05): : 402 - 402
  • [29] First FDA-approved beta-amyloid diagnostic hits the market
    Ken Garber
    Nature Biotechnology, 2012, 30 : 575 - 575
  • [30] FDA-approved peanut allergy treatment The first wave is about to crest
    Tilles, Stephen A.
    Petroni, Daniel
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (02) : 145 - 149
12345